Clinical Trial

Stenting Of Symptomatic Cerebral siNus stenosIs With the laserCut Self-expanding SILANCE Stent

Study acronym: SONIC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this clinical investigation is to evaluate and demonstrate the clinical benefit, performance, and safety of the SILANCE Stent, which is specifically designed for the treatment of patients with symptomatic sinus stenoses associated with IIH.
Trial Details
NCT Number NCT07561268
Lead Sponsor Acandis GmbH
Conditions Idiopathic Intracranial Hypertension (IIH)
Enrollment 99 participants
Start Date 2026-09
Primary Completion 2028-10 (estimated)
Study Completion 2029-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-01